The United States of America has said that a new phase of Lassa fever vaccine clinical trials is set to begin in Nigeria, Liberia and Sierra Leone. This was disclosed in a statement yesterday by the Public Affairs Unit of the United States Diplomatic Mission to Nigeria. Recall that the government had in May slammed a similar ban on travellers from India, Brazil and Turkey over similar concerns. According to the statement, the International AIDS Vaccine Initiative was awarded 22.8 million by the European and Developing Countries Clinical Trial Partnership…
Read MoreNigeria, others to begin Lassa fever vaccine clinical trials
